IL297062A - Systems and methods for detecting the action of electromagnetic viruses - Google Patents
Systems and methods for detecting the action of electromagnetic virusesInfo
- Publication number
- IL297062A IL297062A IL297062A IL29706222A IL297062A IL 297062 A IL297062 A IL 297062A IL 297062 A IL297062 A IL 297062A IL 29706222 A IL29706222 A IL 29706222A IL 297062 A IL297062 A IL 297062A
- Authority
- IL
- Israel
- Prior art keywords
- antennas
- inactivation
- distributed
- entitled
- volume
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 125
- 241000700605 Viruses Species 0.000 title description 150
- 230000002779 inactivation Effects 0.000 title description 132
- 244000052769 pathogen Species 0.000 claims description 6
- 230000001717 pathogenic effect Effects 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 4
- 241000282412 Homo Species 0.000 description 75
- 238000004891 communication Methods 0.000 description 60
- 230000005855 radiation Effects 0.000 description 36
- 230000005540 biological transmission Effects 0.000 description 30
- 210000000234 capsid Anatomy 0.000 description 28
- 238000005516 engineering process Methods 0.000 description 23
- 241000430519 Human rhinovirus sp. Species 0.000 description 21
- 238000003491 array Methods 0.000 description 20
- 239000000443 aerosol Substances 0.000 description 18
- 238000001228 spectrum Methods 0.000 description 17
- 230000001413 cellular effect Effects 0.000 description 13
- 241001678559 COVID-19 virus Species 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 210000003128 head Anatomy 0.000 description 12
- 230000000415 inactivating effect Effects 0.000 description 12
- 241000711573 Coronaviridae Species 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 239000011159 matrix material Substances 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 230000006378 damage Effects 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 210000002845 virion Anatomy 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 239000013598 vector Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 230000001133 acceleration Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 231100000517 death Toxicity 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 4
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000006978 adaptation Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000005672 electromagnetic field Effects 0.000 description 4
- 238000005562 fading Methods 0.000 description 4
- 231100001261 hazardous Toxicity 0.000 description 4
- 206010022000 influenza Diseases 0.000 description 4
- 238000013507 mapping Methods 0.000 description 4
- 230000000116 mitigating effect Effects 0.000 description 4
- 210000001331 nose Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- 238000001069 Raman spectroscopy Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 208000037797 influenza A Diseases 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000001931 thermography Methods 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KJLPSBMDOIVXSN-UHFFFAOYSA-N 4-[4-[2-[4-(3,4-dicarboxyphenoxy)phenyl]propan-2-yl]phenoxy]phthalic acid Chemical compound C=1C=C(OC=2C=C(C(C(O)=O)=CC=2)C(O)=O)C=CC=1C(C)(C)C(C=C1)=CC=C1OC1=CC=C(C(O)=O)C(C(O)=O)=C1 KJLPSBMDOIVXSN-UHFFFAOYSA-N 0.000 description 2
- 208000025721 COVID-19 Diseases 0.000 description 2
- 208000028006 Corneal injury Diseases 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 101710141454 Nucleoprotein Proteins 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002977 hyperthermial effect Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000010408 sweeping Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 239000012873 virucide Substances 0.000 description 2
- 208000035742 Air-borne transmission Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 101000822695 Clostridium perfringens (strain 13 / Type A) Small, acid-soluble spore protein C1 Proteins 0.000 description 1
- 101000655262 Clostridium perfringens (strain 13 / Type A) Small, acid-soluble spore protein C2 Proteins 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 206010069767 H1N1 influenza Diseases 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000337007 Oceania Species 0.000 description 1
- 101000655256 Paraclostridium bifermentans Small, acid-soluble spore protein alpha Proteins 0.000 description 1
- 101000655264 Paraclostridium bifermentans Small, acid-soluble spore protein beta Proteins 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010057430 Retinal injury Diseases 0.000 description 1
- 206010061494 Rhinovirus infection Diseases 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 1
- 206010043521 Throat irritation Diseases 0.000 description 1
- -1 VPI Proteins 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 230000005535 acoustic phonon Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000005557 airborne transmission Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000021167 banquet Nutrition 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004870 electrical engineering Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000004777 protein coat Anatomy 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000002165 resonance energy transfer Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 231100000054 whole-body exposure Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/24—Apparatus using programmed or automatic operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/16—Disinfection, sterilisation or deodorisation of air using physical phenomena
- A61L9/18—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/11—Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/25—Rooms in buildings, passenger compartments
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mobile Radio Communication Systems (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063007358P | 2020-04-08 | 2020-04-08 | |
| US17/224,977 US20210227420A1 (en) | 2012-11-26 | 2021-04-07 | Systems and methods for electromagnetic virus inactivation |
| PCT/US2021/026431 WO2021207527A1 (en) | 2020-04-08 | 2021-04-08 | Systems and methods for electromagnetic virus inactivation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL297062A true IL297062A (en) | 2022-12-01 |
Family
ID=78023666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL297062A IL297062A (en) | 2020-04-08 | 2021-04-08 | Systems and methods for detecting the action of electromagnetic viruses |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4132597A4 (ko) |
| JP (1) | JP2023521415A (ko) |
| KR (1) | KR20220165748A (ko) |
| CN (1) | CN115515650A (ko) |
| AU (1) | AU2021253569A1 (ko) |
| CA (1) | CA3179424A1 (ko) |
| IL (1) | IL297062A (ko) |
| WO (1) | WO2021207527A1 (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114499615B (zh) * | 2022-01-24 | 2023-04-28 | 电子科技大学 | 一种太赫兹通信系统中近远场统一的发射波束成形方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6275738B1 (en) * | 1999-08-19 | 2001-08-14 | Kai Technologies, Inc. | Microwave devices for medical hyperthermia, thermotherapy and diagnosis |
| US20080267142A1 (en) * | 2004-06-18 | 2008-10-30 | Stellaris Ltd. | Distributed Antenna Wlan Access-Point System and Method |
| US20120164022A1 (en) * | 2010-12-22 | 2012-06-28 | Goji Limited | Methods and devices for processing objects by applying electromagnetic (em) energy |
| US9585408B2 (en) * | 2013-10-28 | 2017-03-07 | Elwha Llc | Non-thermal electromagnetic sterilization |
-
2021
- 2021-04-08 KR KR1020227038293A patent/KR20220165748A/ko active Search and Examination
- 2021-04-08 CA CA3179424A patent/CA3179424A1/en active Pending
- 2021-04-08 AU AU2021253569A patent/AU2021253569A1/en active Pending
- 2021-04-08 JP JP2022562108A patent/JP2023521415A/ja active Pending
- 2021-04-08 IL IL297062A patent/IL297062A/en unknown
- 2021-04-08 CN CN202180026704.4A patent/CN115515650A/zh active Pending
- 2021-04-08 EP EP21784799.5A patent/EP4132597A4/en active Pending
- 2021-04-08 WO PCT/US2021/026431 patent/WO2021207527A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4132597A4 (en) | 2024-08-28 |
| WO2021207527A1 (en) | 2021-10-14 |
| JP2023521415A (ja) | 2023-05-24 |
| KR20220165748A (ko) | 2022-12-15 |
| CA3179424A1 (en) | 2021-10-14 |
| CN115515650A (zh) | 2022-12-23 |
| EP4132597A1 (en) | 2023-02-15 |
| AU2021253569A1 (en) | 2022-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bobkova et al. | Focusing of high-intensity ultrasound through the rib cage using a therapeutic random phased array | |
| Darvazehban et al. | Pattern reconfigurable metasurface antenna for electromagnetic torso imaging | |
| Srikanth et al. | A slotted UWB monopole antenna with truncated ground plane for breast cancer detection | |
| IL297062A (en) | Systems and methods for detecting the action of electromagnetic viruses | |
| US11701441B2 (en) | Miniaturized device to sterilize surfaces from Covid-19 and other viruses | |
| WO2017066513A1 (en) | Acoustic automated detection, tracking and remediation of pests and disease vectors | |
| US20210227420A1 (en) | Systems and methods for electromagnetic virus inactivation | |
| Santagati et al. | Opto-ultrasonic communications for wireless intra-body nanonetworks | |
| D’Ammando et al. | Sonodynamic therapy for the treatment of intracranial gliomas | |
| CN102389583A (zh) | 一种杀菌系统 | |
| US20240310475A1 (en) | Electromagnetic wave medical imaging system, device, and methods | |
| WO2014101535A1 (zh) | 一种人体安检系统 | |
| Zou et al. | Tailoring reflected and diffracted wave fields from tessellated acoustic arrays by origami folding | |
| Liu et al. | Comparison of hypocrellin B-mediated sonodynamic responsiveness between sensitive and multidrug-resistant human gastric cancer cell lines | |
| TW202206114A (zh) | 用於電磁病毒失去活性之系統及方法 | |
| Iwase et al. | Antitumor effect of sonodynamically activated pyrrolidine tris-acid fullerene | |
| CN210534345U (zh) | 安检设备 | |
| Faraz et al. | High-Efficiency Geometric Phase Metasurface with Multifold Rotationally Symmetric Resonators | |
| US11471544B2 (en) | Using a steerable beam of RF energy to eliminate viruses and/or bacteria from a volume of air | |
| Roux et al. | Spiral array inspired multi-depth cost function for 2D sparse array optimization | |
| Paul et al. | UWB microwave imaging via modified beamforming for early detection of breast cancer | |
| Gavrilov | Two-dimensional phased arrays for surgical applications: Multiple focus generation and scanning | |
| Yakubov et al. | Wave Diagnostics and Forcing | |
| De Leo et al. | Breath detection of humans buried in a homogeneous lossy medium: A simplified analytical model | |
| US20210268135A1 (en) | Systems and methods for microwave jamming of molecular recognition |